CRISPR cancer trial success paves the way for personalized treatments

‘Most complicated therapy ever’ tailors bespoke, genome-edited immune cells to attack tumours. ‘Most complicated therapy ever’ tailors bespoke, genome-edited immune cells to attack tumours.